JAZ mediates G1 cell cycle arrest by interacting with and inhibiting E2F1
Related Experiment Video
Updated: May 31, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Mingli Yang1, Song Wu, Jinghua Jia
1Department of Medicine, Division of Hematology/Oncology, Shands Cancer Center, University of Florida, Gainesville, FL, USA.
Abstract:
We discovered and reported JAZ as a unique dsRNA binding zinc finger protein that functions as a direct, positive regulator of p53 transcriptional activity to mediate G1 cell cycle arrest in a mechanism involving upregulation of the p53 target gene, p21. We now find that JAZ can also negatively regulate the cell cycle in a novel, p53-independent mechanism resulting from the direct interaction with E2F1, a key intermediate in regulating cell proliferation and tumor suppression. JAZ associates with E2F1's central DNA binding/dimerization region and its C-terminal transactivation domain. Functionally, JAZ represses E2F1 transcriptional activity in association with repression of cyclin A expression and inhibition of G1/S transition. This mechanism involves JAZ-mediated inhibition of E2F1's specific DNA binding activity. JAZ directly binds E2F1 in vitro in a dsRNA-independent manner, and JAZ's dsRNA binding ZF domains, which are necessary for localizing JAZ to the nucleus, are required for repression of transcriptional activity in vivo. Importantly for specificity, siRNA-mediated "knockdown" of endogenous JAZ increases E2F transcriptional activity and releases cells from G1 arrest, indicating a necessary role for JAZ in this transition. Although JAZ can directly inhibit E2F1 activity independently of p53, if functional p53 is expressed, JAZ may exert a more potent inhibition of cell cycle following growth factor withdrawal. Therefore, JAZ plays a dual role in cell cycle regulation by both repressing E2F1 transcriptional activity and activating p53 to facilitate efficient growth arrest in response to cellular stress, which may potentially be exploited therapeutically for tumor growth inhibition.
Insights
JAZ protein regulates the cell cycle through two pathways: activating p53 for G1 arrest and inhibiting E2F1 for proliferation control. This dual role in cell cycle regulation offers potential therapeutic strategies for tumor growth inhibition.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Biology
Background:
- JAZ (JAB1/MPN domain-containing protein) is a dsRNA binding zinc finger protein.
- JAZ was previously identified as a positive regulator of p53 transcriptional activity, mediating G1 cell cycle arrest via p21.
- The cell cycle is tightly regulated by proteins like p53 and E2F1 to control cell proliferation and prevent tumor formation.
Purpose of the Study:
- To investigate the novel mechanisms by which JAZ regulates the cell cycle.
- To determine if JAZ has a role in cell cycle regulation independent of p53.
- To explore the potential therapeutic implications of JAZ's function in cell cycle control.
Main Methods:
- In vitro binding assays to assess JAZ-E2F1 interaction.
- siRNA-mediated knockdown of JAZ to evaluate its role in cell cycle progression.
- Analysis of gene expression, specifically cyclin A, in response to JAZ manipulation.
- Assessment of JAZ's effect on E2F1 DNA binding activity.
Main Results:
- JAZ directly interacts with E2F1, repressing its transcriptional activity and inhibiting G1/S transition.
- JAZ's repression of E2F1 involves inhibiting its DNA binding activity and downregulating cyclin A expression.
- JAZ's dsRNA binding zinc finger domains are essential for its nuclear localization and repression of E2F1 activity.
- Knockdown of JAZ enhances E2F1 activity and releases cells from G1 arrest, confirming JAZ's role in this transition.
- JAZ exhibits a dual role: activating p53 and inhibiting E2F1, leading to potent cell cycle arrest.
Conclusions:
- JAZ functions as a dual regulator of the cell cycle, acting independently of p53 by directly inhibiting E2F1.
- JAZ's interaction with E2F1 represses cell proliferation and contributes to cell cycle arrest.
- The dual role of JAZ in cell cycle regulation presents a potential therapeutic target for inhibiting tumor growth.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System
The Cell Cycle Control System

